Pictet Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$313K Hold
3,259
– – ﹤0.01% 1750
2026
Q1
$356K Buy
3,259
+169
+5% +$16.1K ﹤0.01% 1642
2025
Q4
$251K Hold
3,090
– – ﹤0.01% 1803
2025
Q3
$270K Hold
3,090
– – ﹤0.01% 1709
2025
Q2
$257K Hold
3,090
– – ﹤0.01% 1712
2025
Q1
$259K Buy
3,090
+366
+13% +$34K ﹤0.01% 1693
2024
Q4
$251K Hold
2,724
– – ﹤0.01% 1737
2024
Q3
$253K Buy
+2,724
New +$236K ﹤0.01% 1693

Other funds holding LMAT

Pictet Asset Management's LMAT Position: Q2 2026 in Review

Pictet Asset Management held its LeMaitre Vascular (LMAT) position steady in Q2 2026 at 3,259 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #1750.

Pictet Asset Management first reported a position in LMAT in Q3 2024 and has held it in 8 quarters since. The position peaked at $356K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Pictet Asset Management held 3,259 shares of LeMaitre Vascular worth $313K as of Q2 2026.
  • Pictet Asset Management left its LeMaitre Vascular share count unchanged in Q2 2026.
  • LeMaitre Vascular made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1750 holding.
  • Pictet Asset Management first reported a position in LeMaitre Vascular in Q3 2024 and has held it in 8 quarters since.
  • Pictet Asset Management's LeMaitre Vascular position peaked at $356K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.